Add BrightSurf on Google Email

National Jewish Health


Study finds tezepelumab helps patients with severe asthma reduce oral steroid use while maintaining asthma control

The Phase 3 SUNRISE trial shows that tezepelumab nearly triples the likelihood of reducing daily oral corticosteroid dose in patients with severe, oral corticosteroid-dependent asthma. Patients treated with tezepelumab achieve greater reductions in oral steroid use while maintaining asthma control and improving key clinical outcomes.

SourceNational Jewish Health·JournalThe Lancet Respiratory Medicine·DateMay 28, 2026

Dupilumab restores skin barrier function in children with moderate-to-severe atopic dermatitis, study shows

A new study published in Annals of Allergy, Asthma & Immunology shows that dupilumab treatment significantly restores skin barrier function and reduces inflammation in children with moderate-to-severe atopic dermatitis. The treatment also improves skin health in clinically unaffected areas, highlighting the systemic nature of the disease.

SourceNational Jewish Health·JournalAnnals of Allergy Asthma & Immunology·DateMar 12, 2026

Study finds one-year change on CT scans linked to future outcomes in fibrotic lung disease

Researchers found that small increases in lung scarring over one year signal higher risk of worsening disease, mortality, and steeper declines in lung function. These changes were strongest in patients with less severe disease at baseline, highlighting the potential for earlier intervention to alter disease course.

SourceNational Jewish Health·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateOct 3, 2025

New research links skin barrier dysfunction to pediatric eosinophilic esophagitis

A groundbreaking study suggests that the skin may serve as a biomarker for pediatric eosinophilic esophagitis (EoE), a chronic allergic disease of the esophagus. The study found significant deficits in ceramides, lipid molecules essential for the skin's protective barrier, in children with EoE but without atopic dermatitis.

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·DateJun 6, 2025

New research evaluates the ability of patients with adrenal crisis to complete emergency cortisol injections

A new study explores the ability of individuals with adrenal crisis to accurately and effectively administer emergency cortisol injections. Nearly half of those living with adrenal insufficiency are unable to self-administer life-saving injections during a medical emergency, highlighting the need for improved awareness and preparedness.

SourceNational Jewish Health·JournalEndocrine Practice·DateApr 28, 2025

National Jewish Health researchers identify connection between air pollutants and allergic diseases

A new study by National Jewish Health researchers found that air pollutants can disrupt the skin barrier, contributing to the development and exacerbation of allergic diseases. The study's findings highlight the importance of minimizing exposure to pollutants from an early age, with potential long-term effects on future generations.

SourceNational Jewish Health·JournalAnnals of Allergy Asthma & Immunology·DateApr 22, 2024

Study finds high amounts of silica exposure in previously deployed military veterans

A new study published in International Journal of Environmental Research and Public Health reveals high levels of silica and other silicates in the lungs of military veterans who have deployed since 2001. This research highlights the importance of controlling particulate exposures in military occupational settings to minimize risk for ...

SourceNational Jewish Health·JournalInternational Journal of Environmental Research and Public Health·DateApr 3, 2024

National Jewish Health doctors identify health disparities for indigenous coal miners with black lung disease

Researchers at National Jewish Health found that Indigenous coal miners are more likely to develop disabling black lung disease but have limited access to medical benefits. The study highlights the need for updated lung function standards specific to Indigenous populations to address racial disparities in respiratory health.

SourceNational Jewish Health·JournalAnnals of the American Thoracic Society·DateNov 2, 2023

Study finds children who live close to highly trafficked roads have higher risk of developing atopic dermatitis

A recent study published by National Jewish Health has found that children who live close to highly trafficked roads are more likely to develop atopic dermatitis. The study, which analyzed data from 2008-2021, revealed that living within 500 meters of a highly trafficked road increased the risk of developing atopic dermatitis in children.

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·TypeData/statistical analysis·DateJun 8, 2023

National Jewish Health researchers discover biomarkers that could predict future allergic conditions

Researchers at National Jewish Health have discovered biomarkers on the surface of infant skin that can predict the development of atopic dermatitis and other allergic conditions. The study's findings suggest that targeted therapies such as emollients or biologics may be effective in preventing eczema.

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·TypeObservational study·DateFeb 23, 2023

National Jewish Health led study identifies emerging illnesses from COVID-19 in children

A National Jewish Health led study found that children who develop shortness of breath after COVID-19 infection have evidence of peripheral airway obstruction, leading to persistent fatigue and limited participation in sports and everyday activities. The study identified reversible peripheral airway obstruction and lung hyperinflation ...

SourceNational Jewish Health·JournalJournal of Allergy and Clinical Immunology·TypeObservational study·DateSep 29, 2022

National Jewish Health led study focuses on improving cognitive symptoms of lupus

A National Jewish Health led study found that technology through video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE). The treatment group showed significant improvement in visuomotor speed and complex attentional sequencing skills compared to the control gr...

SourceNational Jewish Health·JournalLupus·TypeRandomized controlled/clinical trial·DateJul 14, 2022

Study reveals root cause of long-term COVID symptoms

Researchers at National Jewish Health have discovered that mitochondria do not function properly in patients with post-COVID syndrome, leading to debilitating symptoms. The study's findings may lead to treatments for patients struggling with fluctuating heart rates, extreme fatigue and memory issues.

SourceNational Jewish Health·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJan 18, 2022